EP1833810

CRYSTALLINE MODIFICATIONS OF N-ALPHA-(2,4,6-TRIISOPROPYLPHENYLSULFONYL)-3-HYDROXYAMIDINO-(L)-PHENYLALANINE-4-ETHOXYCARBONYLPIPERAZIDE AND/OR SALTS THEREOF

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    24.11.2005
  • EP published:
    30.8.2017
  • EP application number:
    05808401.3
  • Max expiry date:
    23.11.2025
  • Title:
    CRYSTALLINE MODIFICATIONS OF N-ALPHA-(2,4,6-TRIISOPROPYLPHENYLSULFONYL)-3-HYDROXYAMIDINO-(L)-PHENYLALANINE-4-ETHOXYCARBONYLPIPERAZIDE AND/OR SALTS THEREOF

Timeline

Today
24.11.2005EP application
30.8.2017EP Publication

Owner

  • Name:
    Heidelberg Pharma AG
  • Address:
    Schriesheimer Strasse 101, 68526, Ladenburg, DE

Inventor

  • Name:
    GRUNENBERG, Alfons
  • Address:
    Dormagen, DE
  • Name:
    LENZ, Jana
  • Address:
    Leinfelden-Echterdingen, DE

Priority

  • Number:
    102004057195
  • Date:
    26.11.2004
  • Country:
    DE

Classification

  • Categories:
    C07D 295/185

Upload documents